Indications and Purposes
| Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: Major Depressive Disorder [See Clinical Studies (14.1)] Generalized Anxiety Disorder [See Clinical Studies (14.2)] Diabetic Peripheral Neuropathy [See Clinical Studies (14.3)] Chronic Musculoskeletal Pain [See Clinical Studies (14.5)] |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Duloxetine Hydrochloride |
|
ZINC1536779 |